CellGENTherapies
CellGEN Therapies produces advanced gene-, cell- and tissue-therapeutic products (ATMPs) for early phase clinical trials according to good manufacturing principles (GMP).
We focus on the development and production of small batches of ATMPs or RNA vaccines as required for personalized medicines or phase I studies. In this way, we preferentially interact with academic researchers as well as companies that have developed personalized ATMPs.
We help UZ Gent, external clients and partners to move their research “from bench to bedside” by providing the right expertise, equipment and a licensed facility for the production of small batches of cell and gene therapeutics.
Achtergrondbeeld:
CellGENTherapies
CellGEN Therapies produces advanced gene-, cell- and tissue-therapeutic products (ATMPs) for early phase clinical trials according to good manufacturing principles (GMP).
We focus on the development and production of small batches of ATMPs or RNA vaccines as required for personalized medicines or phase I studies. In this way, we preferentially interact with academic researchers as well as companies that have developed personalized ATMPs.
We help UZ Gent, external clients and partners to move their research “from bench to bedside” by providing the right expertise, equipment and a licensed facility for the production of small batches of cell and gene therapeutics.
Responsive left-aligned hero with image
Alhoewel de Fransen een heir van tweeënzestigduizend man hadden, waarvan de helft te paard was, kon de minste vrees nu geen plaats meer in het hart der Vlamingen vinden. In hun opgetogenheid verlieten zij dikwijls hun werk om elkander te omhelzen, en dan spraken zij met zegepralende woorden alsof niets hun de overwinning kon ontroven.
